Sanjay Ramakrishnan is an internationally recognised expert in respiratory medicine, particularly in asthma and COPD clinical trials. His work in biomarker guided asthma and COPD attack treatments have been included in guidelines around the world. His work has also delivered the first new treatment for asthma attacks in 50 years. 

Sanjay Ramakrishnan completed his medical school at UWA. He then completed his specialty training in respiratory medicine in Western Australia, before starting his PhD. For his PhD, he was based at the Nuffield Department of Experimental Medicine at the University of Oxford. He also worked as a Lecturer in Physiology at St Peter's College, Oxford. 

Sanjay is now leading the Perth Exacerbation Research (PER) group at the Institute for Respiratory Health, UWA. He also works as a senior lecturer at the UWA Medical School. In addition to his academic responsibilities, Sanjay leads the asthma and COPD clinics at the quarternary respiratory medicine clinic at Sir Charles Gairdner Hospital, Perth, Western Australia. 

Sanjay Ramakrishnan is also active in editorial work. He is the current associate editor for COPD for the journal Respirology. He is also a member of the COPD editorial boards at The American Journal of Respiratory and Criticial Care Medicine and Chest.

In 2023, he was highlighted as the top yound COPD researcher to watch for the next decade by the journal, The Lancet Respiratory Medicine.